Episode
Prescription Rejections Surge Amid Weight Loss Drug Costs | Annapolis News
- Published
- Jul 17, 2026
- Duration seconds
- 91
- Processing state
not_requested- Canonical source
- https://sources.thednn.ai/c15aaefb67b7bc2f
Actions
POST https://stenobird.com/v1/public/podcasts/annapolis-news-today-2-min-news-the-daily-news-now-7681562/episodes/prescription-rejections-surge-amid-weight-loss-drug-costs-annapolis-news/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/annapolis-news-today-2-min-news-the-daily-news-now-7681562/prescription-rejections-surge-amid-weight-loss-drug-costs-annapolis-news.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
One in three brand-name prescriptions are now initially denied by insurers, a 67% jump since 2018, with nearly half never filled—driven largely by skyrocketing demand for weight-loss drugs like Ozempic and Wegovy, which insurers restrict due to cost. A Johns Hopkins study of 2 million prescriptions reveals insurers are slashing coverage, especially for GLP-1 drugs, which face an 85% rejection rate. As states and insurers impose caps, experts urge drugmakers to negotiate lower prices to restore access and curb costs. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/c15aaefb67b7bc2f